Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: Implications for cellular survival and tumor promotion

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3480-3485

  Guyton, Kathryn Z ^a   Gorospe, Myriam ^a   Kensler, Thomas W ^b   Holbrook, Nikki J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; BUTYLCRESOL; GROWTH FACTOR RECEPTOR; HYDROPEROXIDE; METAL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; QUINONE DERIVATIVE; RAS PROTEIN; SURAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FEMALE; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE C FOS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SKIN; TUMOR PROMOTION;

ANIMALS; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOGENS; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; KERATINOCYTES; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; OXIDANTS; QUINONES; RAS PROTEINS; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; STIMULATION, CHEMICAL;

EID: 0029945349     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Taffe, B. G., and Kensler, T. W. Tumor promotion by a hydroperoxide metabolite of burylated hydroxytoluene, 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone Res. Commun. Chem. Pathol. Pharmacol., 61: 291-303, 1988.
2. Taffe, B. G., Takahashi, N., Kensler, T. W., and Mason, R. P. Generation of free radicals from organic hydroperoxide tumor promoters in isolated mouse keratinocytes. J. Biol. Chem., 262: 12143-12149, 1987.
3. Guyton, K. Z., Bhan, P., Kuppusamy, P., Zweier, J. L., Trush, M. A., and Kensler, T. W. Free radical-derived quinone methide mediates skin tumor promotion by butylated hydroxytoluene hydroperoxide expanded role for electrophiles in multistage carcinogenesis. Proc. Natl. Acad. Sci. USA, 88: 946-950, 1991.
4. Cerutti, P. A., and Trump, B. F. Inflammation and oxidative stress in carcinogenesis. Cancer Cells, 3: 1-7, 1991.
5. Guyton, K. Z., and Kensler, T. W. Oxidative mechanisms in carcinogenesis. Br Med. Bull., 49: 523-544, 1993.
6. Toyokuni, S., Okamoto, K., Yodoi, J., and Hiai, H. Persistent oxidative stress in cancer. FEBS Lett., 358: 1-3, 1995.
7. Guyton, K. Z., Thompson, J. A., and Kensler, T. W. Role of quinone methide in the in vitro toxicity of the skin tumor promoter butylated hydroxytoluene hdyroperoxide. Chem. Res. Toxicol., 6: 731-738, 1993.
8. Guyton, K. Z., Dolan, P. M., and Kensler, T. W. Quinone methide mediates in vitro induction of ornithine decarboxylase by the tumor promoter butylated hydroxytoluene hydroperoxide. Carcinogenesis (Lond.), 15: 817-821, 1994.
9. Takahashi, O. 2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide), an active metabolite of BHT causing haemorrhages in rats. Arch. Toxicol., 62: 325-327, 1988.
10. Witschi, H., Malkinson, A. M., and Thompson, J. A. Metabolism and pulmonary toxicity of butylated hydroxytoluene (BHT). Pharmacol. Ther., 42: 89-113, 1989.
11. Bolton, J. L., Valeno, L. G., and Thompson, J. A. The enzymatic formation and chemical reactivity of quinone methides correlate with alkylphenol-induced toxicity in rat hepatocytes. Chem. Res. Toxicol., 5: 816-822, 1992.
12. Seger, R., and Kreb, E. G. The MAPK signaling cascade. FASEB J., 9, 726-735, 1995.
13. Boulikas, T. The phosphorylation connection to cancer (Review). Int. J. Cancer, 6: 271-278, 1995.
14. Mansour, S. J., Matten, W. T., Hermann, A. S., Candie, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., and Ahn, N. G. Transformation of mammalian cells by constitutively active MAPK kinase kinase. Science (Washington DC), 265: 966-970, 1994.
15. Cowley, S., Paterson, H., Kepn, P., and Marshall, C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH-3T3 cells. Cell, 77: 841-852, 1994.
16. Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M., and Yoshida, O. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res., 55: 4182-4187, 1995.
17. Kharasch, M. S., and Joshi, B. S. Reactions of hindered phenols. II. Base-catalyzed oxidations of hindered phenols. J. Org. Chem., 22: 1439-1443, 1957.
18. Wand, M. D., and Thompson, J. A. Cytochrome P-450-catalyzed rearrangement of a peroxyquinol derived from butylated hydroxytoluene. Involvement of radical and cationic intermediates J. Biol. Chem., 261: 14049-14056, 1986.
19. Yuspa, S. H., Morgan, D., Lichti, U., Spangler, E. F., Micheal, D., Kilkenny, A., and Hennings, H. Isolation and characterization of cells derived from mouse skin papillomas induced by an initiation-promotion protocol. Carcinogenesis (Lond.), 7: 949-958, 1986.
20. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.), 369: 156-160, 1994.
21. Liu, Y., Gorospe, M., Yang, C., and Holbrook, N. J. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress J. Biol. Chem., 270: 8377-8380, 1995.
22. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
23. Avruch, S., Zhang, X-F., and Kyriakis, J. M. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci., 19: 279-283, 1994.
24. Burgering, B. M. T., and Bos, J. L. Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem. Sci., 20: 18-22, 1995.
25. Howe, L. R., Leevers, S. J., Gomez, N., Nakielny, S., Cohen, P., and Marshall, C. J. Activation of the MAP kinase pathway by the protein kinase raf Cell, 71: 335-342, 1992.
26. Sachsenmaier, C., Radler-Pohl, A., Zinck, R., Nordheim, A., Herrlich, P., and Rahmsdorf, H. J. Involvement of growth factor receptors in the mammalian UVC response. Cell. 78: 963-972, 1994.
27. Liu, Y., Guyton, K. Z., Gorospe, M., Xu, Q., Lee, J. C., and Holbrook, N. J. Differential activation of ERK, JNK/SAPK and p38/CSBP/RK MAP kinase family members during the cellular response to arsenite. Free Radical Biol. Med., in press, 1996.
28. 2: role in cell survival following oxidant injury. J. Biol. Chem., 271: 4138-4142, 1996.
29. Szeberenyi, J., Hong, C., and Cooper, G. M. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol., 10: 5324-5332, 1990.
30. Szeberenyi, J., Erhardt, P., Cat, H., and Cooper, G. M. Role of Ras in signal transduction from the nerve growth factor receptor: relationship to protein kinase C. calcium and cyclic AMP. Oncogene, 7: 2105-2113, 1992.
31. Davis, R. J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev., 42: 459-467, 1995.
32. Treisman, R. Journey to the surface of the cell: Fos regulation by the SRE. EMBO J., 14: 4905-4913, 1995.
33. Lewis, T., Groom, L. A., Sneddon, A. A., Smythe, C., and Keyse, S. M. XCL100, an inducible nuclear MAP kinase phosphatase from Xenopus laevis: its role in MAPK kinase inactivation in differentiated cells and its expression during early development. J. Cell Sci., 108: 2885-2896, 1995.
34. Marshall, M. S. Ras target proteins in eukaryotic cells. FASEB J., 9: 1311-1318, 1995.
35. Derijard, B., Hibi, M., Wu, I-H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell, 76: 1025-1037, 1994.
36. Cano, E., and Mahadevan, L. C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci., 20: 117-122, 1995.
37. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA, 92: 7686-7689, 1995.
38. Slaga, T. J., DiGiovanni, J., Winberg, L. D., and Budunova, I. V. Skin carcinogenesis: characteristics, mechanisms and prevention. In: R. M. McMlain, T. J. Slaga, R. LeBoeuf, and H. Pitot (eds.), Growth Factors and Tumor Promotion: Implications for Risk Assessment, pp. 1-20. New York: Wiley-Liss, Inc., 1995.
39. Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell, 71: 1081-1091, 1992.
40. 2 stimulate mitogen-activated protein kinase activity in N1H-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res., 54: 12-15, 1994.
41. Chen, Q., Olashaw, N., and Wu, J. Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J. Biol. Chem., 270: 28499-28502, 1995.
42. Schieven, G. L., and Ledbetter, J. A. Activation of tyrosine kinase signal pathways by radiation and oxidative stress. Trends Endocrinol. Metab., 5: 383-388, 1994.
43. Cohen, S. M., and Ellwein, L. B. Cell proliferation in carcinogenesis. Science (Washington DC), 249: 1007-1011, 1990.
44. Reiners, J. J., Kodari, E., Cappel, R. E., and Gilbert, H. F. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Carcinogenesis (Lond.), 12: 2345-2352, 1991.